Olson Charles V
Insider CIK 1663298 · ANTH Chief Technology Officer · SBOT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EDSA Edesa Biotech, Inc. | A Award | 2026-05-27 | 2026-05-29 | 19,000 | — | $0 | 30,000 | SEC↗ |
| EDSA Edesa Biotech, Inc. | A Award | 2025-05-29 | 2025-06-02 | 11,000 | — | $0 | 11,000 | SEC↗ |
| EDSA Edesa Biotech, Inc. | A Award deriv | 2023-07-20 | 2023-07-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EDSA Edesa Biotech, Inc. | A Award deriv | 2023-07-20 | 2023-07-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SBOT Stellar Biotechnologies, I | A Award deriv | 2019-03-12 | 2019-03-13 | 357 | — | $0 | 357 | SEC↗ |
| SBOT Stellar Biotechnologies, I | A Award deriv | 2018-03-12 | 2018-03-14 | 2,500 | — | $0 | 2,500 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2017-05-20 | 2017-05-22 | 43,750 | — | $0 | 43,750 | SEC↗ |
| SBOT Stellar Biotechnologies, I | A Award deriv | 2017-03-23 | 2017-03-27 | 2,500 | — | $0 | 2,500 | SEC↗ |
| SBOT Stellar Biotechnologies, I | A Award deriv | 2016-12-20 | 2016-12-21 | 2,500 | — | $0 | 2,500 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2016-06-09 | 2016-06-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2016-02-12 | 2016-02-16 | 5,626 | — | $0 | 5,626 | SEC↗ |